<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The effects of <z:chebi fb="0" ids="16467,29952">L-arginine</z:chebi> (a precursor of nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi>, NO) on cerebral blood flow (CBF), cerebrovascular resistance (CVR) and metabolites in the ischemic brain were examined in spontaneously hypertensive rats with bilateral carotid <z:mp ids='MP_0006134'>artery occlusion</z:mp> for 30 min followed by 60 min-recirculation </plain></SENT>
<SENT sid="1" pm="."><plain>The administration of <z:chebi fb="0" ids="16467,29952">L-arginine</z:chebi> (300 mg/kg, i.v.) increased the CBF by an average of 11 ml x 100 g-1 x min-1 (P &lt; 0.05 vs. at rest), and N(omega)-<z:chebi fb="13" ids="29785">nitro</z:chebi>-<z:chebi fb="0" ids="16467,29952">L-arginine</z:chebi> (L-NNA, an inhibitor of NO synthase, 5 mg/kg, i.v.) reduced the CBF by 5-6 ml x 100 g-1.min-1 with increase in the mean arterial pressure by 26 mmHg </plain></SENT>
<SENT sid="2" pm="."><plain>During <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> the CBF significantly decreased to below 8% of the resting values in <z:hpo ids='HP_0000001'>all</z:hpo> rats </plain></SENT>
<SENT sid="3" pm="."><plain>The largest blood flow in postischemic hyperemia was 171 +/- 9% of the resting CBF in the rats with <z:chebi fb="0" ids="16467,29952">L-arginine</z:chebi> (P &lt; 0.05 vs. L-NNA and saline), followed by 126 +/- 5 with saline and 109 +/- 3 with L-NNA </plain></SENT>
<SENT sid="4" pm="."><plain>The CVR at 60 min of recirculation was 3.291 +/- 0.144 mmHg  </plain></SENT>
<SENT sid="5" pm="."><plain>ml-1 </plain></SENT>
<SENT sid="6" pm="."><plain>100 g-1 .min-1 in the rats with saline, remained low level of 2.711 +/- 0.124 with <z:chebi fb="0" ids="16467,29952">L-arginine</z:chebi> (P &lt; 0.01 vs. L-NNA and P &lt; 0.05 vs. saline) and in contrast, significantly increased to 5.732 +/- 0.184 with L-NNA (P &lt; 0.01 vs. <z:chebi fb="0" ids="16467,29952">L-arginine</z:chebi> and saline, respectively) </plain></SENT>
<SENT sid="7" pm="."><plain>Tissue <z:chebi fb="4" ids="24996">lactate</z:chebi> with saline increased 2.3-fold at 60 min of recirculation, whereas the increase was inhibited to 1.4-fold after <z:chebi fb="0" ids="16467,29952">L-arginine</z:chebi> treatment (P &lt; 0.01 vs. L-NNA) and in contrast, significantly increased 5.7-fold with L-NNA </plain></SENT>
<SENT sid="8" pm="."><plain>The ATP and <z:chebi fb="105" ids="17234">glucose</z:chebi> levels were better preserved in the rats with <z:chebi fb="0" ids="16467,29952">L-arginine</z:chebi> than in those with L-NNA or saline </plain></SENT>
<SENT sid="9" pm="."><plain>These findings support that the enhanced postischemic hyperemia is beneficial to the ischemic brain and the administration of <z:chebi fb="0" ids="16467,29952">L-arginine</z:chebi> may be potentially useful for the treatment of <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
</text></document>